CA2384840A1 - Utilisation de pramipexole pour traiter l'etat de besoin de cocaine - Google Patents

Utilisation de pramipexole pour traiter l'etat de besoin de cocaine Download PDF

Info

Publication number
CA2384840A1
CA2384840A1 CA002384840A CA2384840A CA2384840A1 CA 2384840 A1 CA2384840 A1 CA 2384840A1 CA 002384840 A CA002384840 A CA 002384840A CA 2384840 A CA2384840 A CA 2384840A CA 2384840 A1 CA2384840 A1 CA 2384840A1
Authority
CA
Canada
Prior art keywords
hydrochloride
treatment
pramipexole
cocaine
craving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002384840A
Other languages
English (en)
Inventor
Jerrold Rosenbaum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2384840A1 publication Critical patent/CA2384840A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des procédés permettant de réduire la dépendance ou l'état de besoin de stimulants. Ces procédés consistent à administrer une quantité thérapeutiquement efficace d'un agoniste de la dopaine, comme le pramipéxole.
CA002384840A 1999-09-30 2000-09-28 Utilisation de pramipexole pour traiter l'etat de besoin de cocaine Abandoned CA2384840A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15686099P 1999-09-30 1999-09-30
US60/156,860 1999-09-30
PCT/US2000/026634 WO2001022820A1 (fr) 1999-09-30 2000-09-28 Utilisation de pramipexole pour traiter l'etat de besoin de cocaine

Publications (1)

Publication Number Publication Date
CA2384840A1 true CA2384840A1 (fr) 2001-04-05

Family

ID=22561399

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002384840A Abandoned CA2384840A1 (fr) 1999-09-30 2000-09-28 Utilisation de pramipexole pour traiter l'etat de besoin de cocaine

Country Status (3)

Country Link
AU (1) AU7620600A (fr)
CA (1) CA2384840A1 (fr)
WO (1) WO2001022820A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011074A1 (es) * 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
ES2432527T3 (es) 2001-12-11 2013-12-04 University Of Virginia Patent Foundation Uso de pramipexol para tratar la esclerosis lateral amiotrófica
US20070196481A1 (en) * 2002-07-25 2007-08-23 Amidon Gregory E Sustained-release tablet composition
US8679533B2 (en) * 2002-07-25 2014-03-25 Pharmacia Corporation Pramipexole once-daily dosage form
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
WO2004060297A2 (fr) * 2002-12-31 2004-07-22 Medtronic Minimed, Inc. Agents de reticulation hydrophiles s'utilisant dans des capteurs enzymatiques
EP2345407A1 (fr) 2004-08-13 2011-07-20 Boehringer Ingelheim International GmbH Formulation d'un tablet avec liberation prolongueé comprennant pramipexole ou un sel pharmaceutiquement acceptable, la methode de la fabrication et l'utilisation du formulation
US8017598B2 (en) 2006-05-16 2011-09-13 Knopp Neurosciences, Inc. Compositions of R(+) and S(−) pramipexole and methods of using the same
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
RU2454409C2 (ru) 2007-03-14 2012-06-27 Нопп Ньюросайенсиз, Инк. Синтез хирально очищенных замещенных бензотиазолдиаминов
CN102186350A (zh) 2008-08-19 2011-09-14 诺普神经科学股份有限公司 使用(r)-普拉克索的组合物与方法
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
LT3019167T (lt) 2013-07-12 2021-03-25 Knopp Biosciences Llc Eozinofilų ir (arba) bazofilų padidintų kiekių gydymas
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
DK3033081T3 (da) 2013-08-13 2021-05-31 Knopp Biosciences Llc Sammensætninger og fremgangsmåder til behandling af kronisk urticaria
US9642840B2 (en) 2013-08-13 2017-05-09 Knopp Biosciences, Llc Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders

Also Published As

Publication number Publication date
WO2001022820A1 (fr) 2001-04-05
AU7620600A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
CA2384840A1 (fr) Utilisation de pramipexole pour traiter l'etat de besoin de cocaine
US6750235B1 (en) Pramipexole as a treatment for cocaine craving
JP2011102319A (ja) 睡眠／覚醒サイクルの正規化のための化合物
AU2005206139B2 (en) Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss
US20040029941A1 (en) Zonisamide use in obesity and eating disorders
US20080214592A1 (en) Methods of treating anxiety disorders
AU2002336765B2 (en) Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
AU2002336765A1 (en) Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
US20060217344A1 (en) Compounds for the treatment of tobacco dependence and withdrawal
CN114072150A (zh) 新方法
US20110244057A1 (en) Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions
CN117797155B (zh) 对抗氯胺酮毒性的药物制剂
Gupta et al. Phentermine and topiramate combination for chronic weight management: a review
MXPA04006126A (es) Acero para herramientas de arranque de viruta.
CA2338330A1 (fr) Procedes et compositions permettant de traiter et de prevenir certains troubles psychiatriques et medicaux par le moclobemide
Rogawski Antiseizure Medications
Den Boer et al. S. 20.04 Challenge studies in obsessive-compulsive disorder; a key to the pathogenesis?
Din et al. Guideline to the Three New Antidepressants
WO2004037238A1 (fr) Nouvelles utilisations de deramciclane

Legal Events

Date Code Title Description
FZDE Discontinued